Gene · 2217
Papers4,523
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,523
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The temporal sequence of myasthenia gravis and neuromyelitis optica spectrum disorder: a case report and systematic review of 74 patients. | Front Neurol | 2026 | 41767003 | PubTator, text mining | PubMed |
| Neuronal autoantibodies in neurodegenerative dementia: From evidence to clinical framework. | J Prev Alzheimers Dis | 2026 | 41763102 | PubTator, text mining | PubMed |
| Progress in the Treatment of Refractory Myasthenia Gravis. | Rev Neurol | 2026 | 41761996 | PubTator, text mining | PubMed |
| Early versus late add-on therapy in generalized myasthenia gravis: a multicenter real-world cohort study. | J Neurol | 2026 | 41760990 | PubTator, text mining | PubMed |
| QX008N, an Anti-TSLP Monoclonal Antibody: Pharmacokinetics, Tolerability, and Immunogenicity in Healthy Chinese Subjects. | Clin Transl Sci | 2026 | 41757744 | PubTator, text mining | PubMed |
| Phage Display Technology: Design, Library Construction, and Panning Strategies for Antibody Development. | Biomol Ther (Seoul) | 2026 | 41755773 | PubTator, text mining | PubMed |
| Pharmaceutical Strategies for West Nile Virus in Europe, an Underrecognized Cause of Severe Disease and Mortality in Older Adults: From Supportive Care to Antiviral Development. | Pharmaceuticals (Basel) | 2026 | 41754842 | PubTator, text mining | PubMed |
| Organoids Gone Viral: A Comprehensive Review on Human Organoid Models to Study Viral Pathogenesis. | Viruses | 2026 | 41754581 | PubTator, text mining | PubMed |
| A Prediction Model for Uncoating Receptor Usage in Human Enteroviruses Based on Amino Acid Sequences and a Naive Bayes Algorithm. | Viruses | 2026 | 41754579 | PubTator, text mining | PubMed |
| Perinatal Antibiotic Timing Impairs Maternal IgG Transfer via FcRn and Shapes the Neonatal Gut Microbiome in Mice. | Microorganisms | 2026 | 41753563 | PubTator, text mining | PubMed |
| A Clinician Perspective for a Personalized Approach to Management of Chronic Immune Thrombocytopenia with Targeted Therapies Alone or in Combination. | J Clin Med | 2026 | 41753312 | PubTator, text mining | PubMed |
| mRNA-Encoded Antibodies: An Emerging Paradigm in Antiviral Protection. | Biomolecules | 2026 | 41750365 | PubTator, text mining | PubMed |
| Evolution of Immune Checkpoint Blockade in Metastatic NSCLC: A Narrative Review of Emerging Bispecific Antibodies and the Practical Challenges of Clinical Integration. | Cancers (Basel) | 2026 | 41749962 | PubTator, text mining | PubMed |
| Current status and challenges of biologic targeted therapy for myasthenia gravis in China. | Intractable Rare Dis Res | 2026 | 41744014 | PubTator, text mining | PubMed |
| Systemic Immunity Triggered by Boron Neutron Capture Therapy via Manganese-Borate Complex. | Mater Today Bio | 2026 | 41743161 | PubTator, text mining | PubMed |
| Clinical course and prognosis of chronic autoimmune neuropathies requiring intensive care: a retrospective cohort study. | J Neurol | 2026 | 41739210 | PubTator, text mining | PubMed |
| Telitacicept for refractory AChR-positive generalized myasthenia gravis: a retrospective real-world study. | Front Immunol | 2026 | 41737228 | PubTator, text mining | PubMed |
| Engineered Exosomes: Advances in Therapeutic Applications for Otolaryngology-Head and Neck Diseases. | Int J Nanomedicine | 2026 | 41737047 | PubTator, text mining | PubMed |
| Real-World Outcomes of Efgartigimod in Adult Myasthenia Gravis. | Cureus | 2026 | 41728453 | PubTator, text mining | PubMed |
| Immunoglobulin G N-glycosylation remodeling in viral infections: immunomodulatory roles and potential biomarker implications. | Front Immunol | 2026 | 41727429 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2217/papers?page=9